Illumina Inc
ILMN
Common Stock
$135.14
Sector: Health Care
Industry: Life Sciences Tools & Services
Sub-Industry: Life Sciences Tools & Services
Exposures: Genetics Tools
|
|
|
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
(Diluted) Earnings Per Share | -$28.05 | $5.05 | $4.43 | $6.72 | $5.54 |
Sales/Revenue | $4.58 B | $4.53 B | $3.24 B | $3.54 B | $3.33 B |
Sales Growth | 1.28% | 39.73% | -8.58% | 6.30% | 0.00% |
Gross Margin | +64.83 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -$4.40 B | $762.00 M | $656.00 M | $1.00 B | $826.00 M |
Net Income Growth | -677.95% | 16.16% | -34.53% | 21.31% | 0.00% |
Net Margin | -96.07 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | $748.00 M | $537.00 M | $767.00 M | $1.18 B | $1.06 B |
Cost of Goods Sold (incl D&A) | $1.61 B | $1.37 B | $1.02 B | $1.08 B | $1.01 B |
Cost of Goods Sold (excl D&A) | $1.22 B | $1.12 B | $829.00 M | $888.00 M | $827.00 M |
Cost of Goods Growth | 17.49% | 35.04% | -5.58% | 6.96% | 0.00% |
Research & Development | $1.32 B | $1.19 B | $682.00 M | $647.00 M | $623.00 M |
Other SG&A Expenses | $1.30 B | $1.68 B | $941.00 M | $827.00 M | $794.00 M |
Interest Expense | $26.00 M | $61.00 M | $49.00 M | $52.00 M | $57.00 M |
Income Tax | $68.00 M | $122.00 M | $200.00 M | $128.00 M | $112.00 M |
2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | |
---|---|---|---|---|
(Diluted) Earnings Per Share | -$0.89 | -$24.31 | -$3.41 | $0.54 |
Sales/Revenue | $1.08 B | $1.12 B | $1.16 B | $1.22 B |
Sales Growth | -2.87% | -4.04% | -4.99% | 2.09% |
Gross Margin | +64.83 | 0.00 | 0.00 | 0.00 |
Net Income | -$140.00 M | -$3.82 B | -$535.00 M | $86.00 M |
Net Income Growth | 96.33% | -613.27% | -722.09% | -23.21% |
Net Margin | -96.07 | 0.00 | 0.00 | 0.00 |
EBITDA | $86.00 M | $349.00 M | $124.00 M | $275.00 M |
Cost of Goods Sold (incl D&A) | $411.00 M | $398.00 M | $395.00 M | $408.00 M |
Cost of Goods Sold (excl D&A) | $306.00 M | $295.00 M | $301.00 M | $317.00 M |
Cost of Goods Growth | 3.27% | 0.76% | -3.19% | 7.09% |
Research & Development | $339.00 M | $325.00 M | $327.00 M | $323.00 M |
Other SG&A Expenses | $352.00 M | $146.00 M | $410.00 M | $308.00 M |
Interest Expense | $9.00 M | $6.00 M | $6.00 M | $6.00 M |
Income Tax | -$28.00 M | $144.00 M | -$102.00 M | $54.00 M |
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $1.74 B | $1.70 B | $1.45 B | $1.44 B | $1.08 B |
Cash and Short-Term Investment | $2.04 B | $1.34 B | $3.47 B | $3.41 B | $3.51 B |
Cash and Short-Term Investment Growth | 52.13% | -61.43% | 1.70% | -2.79% | 0.00% |
Long Term Debt | $2.23 B | $2.47 B | $1.34 B | $1.84 B | $890.00 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $12.25 B | $15.22 B | $7.59 B | $7.32 B | $6.96 B |
Total Assets Growth | -19.48% | 100.62% | 3.68% | 5.13% | 0.00% |
Inventories | $568.00 M | $431.00 M | $372.00 M | $359.00 M | $386.00 M |
Finished Goods | $28.00 M | $27.00 M | $22.00 M | $26.00 M | $51.00 M |
Short Term Debt | $1.32 B | $71.00 M | $562.00 M | $45.00 M | $1.11 B |
Total Liabilities | $5.65 B | $4.48 B | $2.89 B | $2.70 B | $3.05 B |
2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $1.74 B | $1.75 B | $1.75 B | $1.74 B | $1.70 B |
Cash and Short-Term Investment | $2.04 B | $1.04 B | $1.33 B | $1.42 B | $1.34 B |
Cash and Short-Term Investment Growth | 95.68% | -21.55% | -6.29% | 5.75% | 0.00% |
Long Term Debt | $2.23 B | $1.24 B | $1.27 B | $2.04 B | $2.47 B |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $12.25 B | $11.26 B | $15.45 B | $15.27 B | $15.22 B |
Total Assets Growth | 8.85% | -27.14% | 1.14% | 0.37% | 0.00% |
Inventories | $568.00 M | $559.00 M | $518.00 M | $465.00 M | $431.00 M |
Finished Goods | $28.00 M | $29.00 M | $32.00 M | $32.00 M | $27.00 M |
Short Term Debt | $1.32 B | $1.32 B | $1.32 B | $571.00 M | $71.00 M |
Total Liabilities | $5.65 B | $4.53 B | $5.00 B | $4.38 B | $4.48 B |
Expiration Date | Call To Put Ratio | Open Money on Chain |
---|---|---|
2024-09-20 | 0.8 | $188.20 K |
2024-12-20 | 0.96 | $332.60 K |
2025-01-17 | 1.05 | $1.34 M |
Quarter | Amount | Yield |
---|
|
|